pharmayouth ltd.
pharmayouth ltd. Company Information
Company Number
09884677
Website
-Registered Address
ams accountants medical limited, floor 2, manchester, M1 3BE
Industry
Manufacture of basic pharmaceutical products
Telephone
-
Next Accounts Due
August 2024
Group Structure
View All
Shareholders
mehraan sattar 50%
hussain abdeh 50%
pharmayouth ltd. Estimated Valuation
Pomanda estimates the enterprise value of PHARMAYOUTH LTD. at £161k based on a Turnover of £170.4k and 0.94x industry multiple (adjusted for size and gross margin).
pharmayouth ltd. Estimated Valuation
Pomanda estimates the enterprise value of PHARMAYOUTH LTD. at £56.3k based on an EBITDA of £12.6k and a 4.46x industry multiple (adjusted for size and gross margin).
pharmayouth ltd. Estimated Valuation
Pomanda estimates the enterprise value of PHARMAYOUTH LTD. at £11.7k based on Net Assets of £5.4k and 2.18x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharmayouth Ltd. AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Pharmayouth Ltd. Overview
Pharmayouth Ltd. is a live company located in manchester, M1 3BE with a Companies House number of 09884677. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in November 2015, it's largest shareholder is mehraan sattar with a 50% stake. Pharmayouth Ltd. is a young, micro sized company, Pomanda has estimated its turnover at £170.4k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pharmayouth Ltd. Health Check
Pomanda's financial health check has awarded Pharmayouth Ltd. a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs
1 Strong
3 Regular
6 Weak
Size
annual sales of £170.4k, make it smaller than the average company (£26.7m)
- Pharmayouth Ltd.
£26.7m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Pharmayouth Ltd.
- - Industry AVG
Production
with a gross margin of 37.2%, this company has a comparable cost of product (37.2%)
- Pharmayouth Ltd.
37.2% - Industry AVG
Profitability
an operating margin of 7.4% make it as profitable than the average company (7.4%)
- Pharmayouth Ltd.
7.4% - Industry AVG
Employees
with 2 employees, this is below the industry average (130)
2 - Pharmayouth Ltd.
130 - Industry AVG
Pay Structure
on an average salary of £54.6k, the company has an equivalent pay structure (£54.6k)
- Pharmayouth Ltd.
£54.6k - Industry AVG
Efficiency
resulting in sales per employee of £85.2k, this is less efficient (£266.5k)
- Pharmayouth Ltd.
£266.5k - Industry AVG
Debtor Days
it gets paid by customers after 5 days, this is earlier than average (58 days)
- Pharmayouth Ltd.
58 days - Industry AVG
Creditor Days
its suppliers are paid after 4 days, this is quicker than average (40 days)
- Pharmayouth Ltd.
40 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Pharmayouth Ltd.
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 4 weeks, this is less cash available to meet short term requirements (13 weeks)
4 weeks - Pharmayouth Ltd.
13 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 68.5%, this is a higher level of debt than the average (45.9%)
68.5% - Pharmayouth Ltd.
45.9% - Industry AVG
pharmayouth ltd. Credit Report and Business Information
Pharmayouth Ltd. Competitor Analysis
Perform a competitor analysis for pharmayouth ltd. by selecting its closest rivals and benchmarking them against 12 key performance metrics.
pharmayouth ltd. Ownership
PHARMAYOUTH LTD. group structure
Pharmayouth Ltd. has no subsidiary companies.
Ultimate parent company
PHARMAYOUTH LTD.
09884677
pharmayouth ltd. directors
Pharmayouth Ltd. currently has 2 directors. The longest serving directors include Mr Mehraan Sattar (Nov 2015) and Mr Hussain Abdeh (Nov 2015).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Mehraan Sattar | England | 32 years | Nov 2015 | - | Director |
| Mr Hussain Abdeh | United Kingdom | 31 years | Nov 2015 | - | Director |
PHARMAYOUTH LTD. financials
Pharmayouth Ltd.'s latest turnover from November 2022 is estimated at £170.4 thousand and the company has net assets of £5.4 thousand. According to their latest financial statements, Pharmayouth Ltd. has 2 employees and maintains cash reserves of £108 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|
| Turnover | |||||||
| Other Income Or Grants | |||||||
| Cost Of Sales | |||||||
| Gross Profit | |||||||
| Admin Expenses | |||||||
| Operating Profit | |||||||
| Interest Payable | |||||||
| Interest Receivable | |||||||
| Pre-Tax Profit | |||||||
| Tax | |||||||
| Profit After Tax | |||||||
| Dividends Paid | |||||||
| Retained Profit | |||||||
| Employee Costs | |||||||
| Number Of Employees | 2 | 2 | |||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|
| Tangible Assets | 4,800 | 0 | 49,000 | 0 | 0 | 0 | 0 |
| Intangible Assets | 9,449 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 3 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 14,249 | 0 | 49,000 | 3 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 2,655 | 0 | 1,003 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 108 | 6,351 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,763 | 6,351 | 1,003 | 0 | 0 | 0 | 0 |
| total assets | 17,012 | 6,351 | 50,003 | 3 | 0 | 0 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 1,200 | 401 | 400 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 1,200 | 401 | 400 | 0 | 0 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 10,456 | 10,905 | 50,000 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 10,456 | 10,905 | 50,000 | 0 | 0 | 0 | 0 |
| total liabilities | 11,656 | 11,306 | 50,400 | 0 | 0 | 0 | 0 |
| net assets | 5,356 | -4,955 | -397 | 3 | 0 | 0 | 0 |
| total shareholders funds | 5,356 | -4,955 | -397 | 3 | 0 | 0 | 0 |
| Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Profit | |||||||
| Depreciation | 0 | ||||||
| Amortisation | 0 | ||||||
| Tax | |||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 2,655 | -1,003 | 1,003 | 0 | 0 | 0 | 0 |
| Creditors | 799 | 1 | 400 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||
| Investing Activities | |||||||
| capital expenditure | |||||||
| Change in Investments | 0 | 0 | -3 | 3 | 0 | 0 | 0 |
| cash flow from investments | |||||||
| Financing Activities | |||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | -449 | -39,095 | 50,000 | 0 | 0 | 0 | 0 |
| share issue | |||||||
| interest | |||||||
| cash flow from financing | |||||||
| cash and cash equivalents | |||||||
| cash | -6,243 | 6,351 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -6,243 | 6,351 | 0 | 0 | 0 | 0 | 0 |
P&L
November 2022turnover
170.4k
-45%
operating profit
12.6k
0%
gross margin
37.3%
-7.67%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2022net assets
5.4k
-2.08%
total assets
17k
+1.68%
cash
108
-0.98%
net assets
Total assets minus all liabilities
Similar Companies
pharmayouth ltd. company details
company number
09884677
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
incorporation date
November 2015
age
9
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
ams accountants medical limited, floor 2, manchester, M1 3BE
last accounts submitted
November 2022
pharmayouth ltd. Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pharmayouth ltd..
pharmayouth ltd. Companies House Filings - See Documents
| date | description | view/download |
|---|
